Analysed APREA THERAPEUTICS INC (APRE:NASDAQ) News Sources
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
21-04-2026
yahoo.com
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
01-04-2026
yahoo.com
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
13-05-2026
yahoo.com
Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors
01-06-2026
yahoo.com
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
30-07-2026
yahoo.com
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
28-08-2026
yahoo.com
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
10-09-2026
yahoo.com
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
22-09-2026
yahoo.com
What is the current price of APREA THERAPEUTICS INC (APRE:NASDAQ)?
The current price of APREA THERAPEUTICS INC (APRE:NASDAQ) is $0.6044.
APREA THERAPEUTICS INC (APRE:NASDAQ) absolute price change since previous trading day?
The absolute price change of APREA THERAPEUTICS INC (APRE:NASDAQ) since the previous trading day is $0.0462.
APREA THERAPEUTICS INC (APRE:NASDAQ) percentage price change since previous trading day?
The percentage price change of APREA THERAPEUTICS INC (APRE:NASDAQ) since the previous trading day is 8.2766%.
What is the most recent average sentiment score for APREA THERAPEUTICS INC (APRE:NASDAQ)?
The most recent average sentiment score for APREA THERAPEUTICS INC (APRE:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for APREA THERAPEUTICS INC (APRE:NASDAQ)?
The most recent sentiment for APREA THERAPEUTICS INC (APRE:NASDAQ) is .
SEC-8K** Filing Available For APREA THERAPEUTICS INC (APRE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.